NM_005506.4:c.1403C>G
Variant summary
Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4
The NM_005506.4(SCARB2):c.1403C>G(p.Thr468Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T468I) has been classified as Uncertain significance.
Frequency
Consequence
NM_005506.4 missense
Scores
Clinical Significance
Conservation
Publications
- action myoclonus-renal failure syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
- progressive myoclonus epilepsyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- Unverricht-Lundborg syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SCARB2 | NM_005506.4 | c.1403C>G | p.Thr468Arg | missense_variant | Exon 12 of 12 | ENST00000264896.8 | NP_005497.1 | |
SCARB2 | NM_001204255.2 | c.974C>G | p.Thr325Arg | missense_variant | Exon 9 of 9 | NP_001191184.1 | ||
SCARB2 | XM_047416429.1 | c.929C>G | p.Thr310Arg | missense_variant | Exon 12 of 12 | XP_047272385.1 | ||
SCARB2 | XM_047416430.1 | c.929C>G | p.Thr310Arg | missense_variant | Exon 12 of 12 | XP_047272386.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Action myoclonus-renal failure syndrome Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at